Usability and Implementation Considerations of Fitbit and App Intervention for Diverse Cancer Survivors: Mixed Methods Study
JMIR Cancer · 2025
DOI: 10.2196/60034 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift JMIR Cancer, 2025. Verfasst von Zakery Dabbagh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, 55 N Lake Ave, Worcester, MA, 01655, Unit…. Hauptthemen laut MEDLINE: Cancer Survivors, Mobile Applications, Fitness Trackers, Exercise. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
Despite the known benefits of physical activity, cancer survivors remain insufficiently active. Prior trials have adopted digital health methods, although several have been pedometer-based and enrolled mainly female, non-Hispanic White, and more highly educated survivors of breast cancer.
Objective
The objective of this study was to test a previously developed mobile health system consisting of a Fitbit activity tracker and the MyDataHelps smartphone app for feasibility in a diverse group of cancer survivors, with the goal of refining the program and setting the stage for a larger future trial.
Methods
Participants were identified from one academic medical center’s electronic health records, referred by a clinician, or self-referred to participate in the study. Participants were screened for eligibility, enrolled, provided a Fitbit activity tracker, and instructed to download the Fitbit: Health & Wellness and MyDataHelps apps. They completed usability surveys at 1 and 3 months. Interviews were conducted at the end of the 3-month intervention with participants and cancer care clinicians to assess the acceptability of the intervention and the implementation of the intervention into clinical practice, respectively. Descriptive statistics were calculated for demographics, usability surveys, and Fitbit adherence and step counts. Rapid qualitative analysis was used to identify key findings from interview transcriptions.
Results
Of the 100 patients screened for eligibility, 31 were enrolled in the trial (mean age 64.8, SD 11.1 years; female patients=17/31, 55%; Hispanic or Latino=7/31, 23%; non-White=11/31, 35%; less than a bachelor’s degree=14/31, 45%; and household income
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, 55 N Lake Ave, Worcester, MA, 01655, United States, 1 (774) 455-3744.
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.
- Center for Healthcare Organization and Implementation Research, Bedford VA Healthcare System, Bedford, MA, United States.
ORCID-Profile: Zakery Dabbagh, Reem Najjar, Ariana Kamberi, Ben S Gerber, Aditi Singh, Apurv Soni, Sarah L Cutrona, David D McManus, Jamie M Faro
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
Zitieren
APA
Dabbagh, Z., Najjar, R., Kamberi, A., Gerber, B. S., Singh, A., Soni, A., Cutrona, S. L., McManus, D. D., & Faro, J. M. (2025). Usability and Implementation Considerations of Fitbit and App Intervention for Diverse Cancer Survivors: Mixed Methods Study. JMIR Cancer. https://doi.org/10.2196/60034
Vancouver
Dabbagh Z, Najjar R, Kamberi A, Gerber BS, Singh A, Soni A, et al. Usability and Implementation Considerations of Fitbit and App Intervention for Diverse Cancer Survivors: Mixed Methods Study. JMIR Cancer. 2025. doi:10.2196/60034
BibTeX
@article{Dabbagh2025,
author = {Dabbagh, Zakery and Najjar, Reem and Kamberi, Ariana and Gerber, Ben S and Singh, Aditi and Soni, Apurv and Cutrona, Sarah L and McManus, David D and Faro, Jamie M},
title = {Usability and Implementation Considerations of Fitbit and App Intervention for Diverse Cancer Survivors: Mixed Methods Study},
journal = {JMIR Cancer},
year = {2025},
doi = {10.2196/60034}
}
EUVIMED